in

FDA, NIH, Veteran Affairs Partner with America Makes for 3D Printing Innovations During Pandemic Response

Replistruder Syringe-Based Extruder. Credit: NIH 3D Print Exchange

The federal government this week took steps to formalize a collaboration framework to facilitate regulatory and basic science innovation with 3D printing technologies to respond to COVID-19.

The FDA entered into a Memorandum of Understanding (MOU) with the Department of Veterans Affairs and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID) to advance utilization of 3D printing to fill critical supply shortfalls and innovate solutions during the COVID-19 pandemic public health emergency.

These federal partners are working with America Makes, the National Additive Manufacturing Innovation Institute, to facilitate connections between patients and healthcare providers, local manufacturers with capabilities, and designs for needed medical products.

Through this collaboration, the U.S. government and partners will aims to ensure that veterans and civilians have access to the most innovative medical solutions and technologies, including medical products that are manufactured close to the patient or at point-of-care. The FDA also issued FAQs on 3D Printing of Medical Devices During COVID-19 for entities who 3D print devices, accessories, components, and/or parts during the COVID-19 pandemic.

Highlighted NIH 3D Print Exchange Prototypes:

A pregnant woman walks past a street mural in Hong Kong on March 23, 2020

Pregnant in a Time of Coronavirus – The Changing Risks and What You Need to Know

Duke Starts Innovative Decon of N95 Masks Using Vaporized Hydrogen Peroxide to Alleviate Shortages